Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 27299990.
- Also identified by DOI 10.1371/journal.pmed.1002043 and PMC identifier 4907461.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics.
Medical subject headings
- Anti-Bacterial Agents
- Commerce
- Drug Industry
- Investments
- Pharmaceutical Research